98634064 - SYNWEAVE

Information

  • Trademark
  • 98634064
  • Serial Number
    98634064
  • Filing Date
    July 05, 2024
    2 months ago
  • Transaction Date
    July 05, 2024
    2 months ago
  • Status Date
    July 05, 2024
    2 months ago
Mark Drawing Code
4
Mark Identification
SYNWEAVE
Case File Statements
  • GS0401: Contract manufacturing and custom manufacturer for biopharmaceutical companies for process development of manufacturing process of biologics namely, create a standard process and material for part of manufacturing process such as cell line development, clone selection, analytical methods, formulation, scale-up of the manufacturing process, manufacture of drug substance and drug product, viral testing and viral clearance studies.
  • GS0051: Bio-logical and bio-technological products pertaining to pharmaceutical and medical industries and formulations thereof; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; proteins; antibodies; synthetic peptides for pharmaceutical purposes; nucleic acid sequences and biochemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for use in oncology; biopharmaceuticals for the treatment of cancer; cell, viral vectors and proteins for medical use; medicines for veterinary purposes; biological preparations for medical purposes; biochemicals for use in DNA analysis [medical]; diagnostic kits consisting primarily of monoclonal antibodies, recombinant proteins, and nucleic acids for use in disease testing; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids.
  • GS0011: Bio-technological products including, mammalian cells, antibodies, proteins, carbohydrates, enzymes, lipids, and nucleic acids, DNA products, immunological re-agents, and biochemicals including organic intermediates; active biochemical ingredients for use in the manufacture of biopharmaceuticals for treating diseases and conditions; biochemicals for industrial use; assays for research purposes; biomedical compounds, namely, antibodies, recombinant proteins, antibodies, , protein carbohydrates, enzymes, lipids, and nucleic acids, peptide substrates used in analysing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; biochemical polymers; biochemicals for use in biotechnological product development; proteins; cells for scientific, laboratory or medical research; reagents for use in the development of antibodies, proteins, nucleic acids [other than for medical or veterinary purposes]; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; protein arrays and nucleotide arrays for scientific and medical research; peptides for industrial purposes; proteins for use in recombinant DNA technology [other than for medical use]; specialty chemicals, namely, chemical additives for general industrial use in the manufacture of a wide variety of goods; reference standards [chemicals] for use in science and industry; biochemicals for in vitro and in vivo scientific use; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; assays for research purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology.
  • GS0441: Services for creating scientific research and development of process and products relating to medical diagnostic testing and monitoring.
  • GS0421: Scientific research and development for biopharmaceutical companies in the field of biologics such as antibodies, proteins, cells, nucleic acids; custom design and development of biochemicals and biopharmaceuticals; laboratory testing; laboratory testing services; testing of pharmaceuticals; biochemical engineering; biopharmaceutical drug development services; biopharmaceutical products development; biopharmaceutical substance and products manufacturing; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of proteins, antibodies, antibody technology; custom design and development of biochemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of biochemicals, materials customization for medical, scientific, and technological applications; viral testing services; viral testing analysis; toxicity testing for research purposes; conducting and providing tests and supporting analysis for clinical trials; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; analytical services for scientific research purposes; laboratory research in the field of protein expression; scientific services relating to the isolation and cultivation of human tissues and cells; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical, biologics, biotechnology, biotherapeutics, biology, biochemical, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic,; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibody, API, biomolecules, cell bank characterization, chiral, chromosome aberration, clinical chemistry, cloning vector, , DNA, flow cytometry, mass spectrometry, gene, immuno-pharmaceuticals, in vitro assays, large molecule, liquid chromatography mass spectrometry, microbial, monomer, nanoparticle, natural products, peptides, proteins, RNA, supercritical fluid chromatography, vaccines.
Case File Event Statements
  • 7/5/2024 - 2 months ago
    1 - NEW APPLICATION ENTERED Type: NWAP